4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-26-009764
Chief Scientific Officer gave up 2,026 shares (to pay taxes)
- Chief Scientific Officer acquired 6,663 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Garfield Alastair Chief Scientific Officer | 2026-02-01 | Option exercise | +6,663 | 9,789 | D | ||
| Garfield Alastair Chief Scientific Officer | 2026-02-01 | Shares withheld for taxes | −2,026 | $108.99 | $220,814 | 7,763 | D |
| Derivatives | |||||||
| Garfield Alastair Chief Scientific Officer | 2026-02-01 | Option exercise · Restricted Stock Units | −6,663 | 19,987 | D | ||
Loading xslF345X05/tm264963-2_4seq1.xml…